Skip to content

Clinical trials

Phase 3 Leukemia, Myeloid, Acute trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 3 Country / region: New Zealand Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20152
20161
20172
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Children's Oncology Group2
Astellas Pharma Global Development, Inc.1
Hoffmann-La Roche1
National Cancer Institute (NCI)1
Otsuka Australia Pharmaceutical Pty Ltd1
PedAL BCU, LLC1
Sunesis Pharmaceuticals1
University of Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute11
Leukemia3
Myelodysplastic Syndromes2
Neoplasms2
Congenital Abnormalities1
Down Syndrome1
Hematologic Diseases1
Leukemia, Basophilic, Acute1
Leukemia, Eosinophilic, Acute1
Leukemia, Erythroblastic, Acute1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.